BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chang S, Malter L, Hudesman D. Disease monitoring in inflammatory bowel disease. World J Gastroenterol 2015; 21(40): 11246-11259 [PMID: 26523100 DOI: 10.3748/wjg.v21.i40.11246]
URL: https://www.wjgnet.com/1007-9327/full/v21/i40/11246.htm
Number Citing Articles
1
Yoshihiro Tatsumi, Kazuki Kakimoto, Azusa Hara, Noboru Mizuta, Keijiro Numa, Naohiko Kinoshita, Kei Nakazawa, Ryoji Koshiba, Yuki Hirata, Kazuhiro Ota, Takako Miyazaki, Shiro Nakamura, Kayoko Sakagami, Shoko Arimitsu, Hiroaki Ito, Hiroki Nishikawa. Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative ColitisJournal of Clinical Medicine 2023; 12(22): 7165 doi: 10.3390/jcm12227165
2
Jared Matson, Sonia Ramamoorthy, Nicole E. Lopez. The Role of Biomarkers in Surgery for Ulcerative Colitis: A ReviewJournal of Clinical Medicine 2021; 10(15): 3362 doi: 10.3390/jcm10153362
3
Grazyna Piotrowicz, Agnieszka Klufczyńska, Jacek Kowerzanow, Piotr Banaszkiewicz,, Grażyna Rydzewska. Crohn’s disease activity evaluation based on imaging studies and biomarkersGastroenterology & Hepatology: Open Access 2018; 9(2) doi: 10.15406/ghoa.2018.09.00292
4
Gabriele Dragoni, Tommaso Innocenti, Andrea Galli. Biomarkers of Inflammation in Inflammatory Bowel Disease: How Long before Abandoning Single-Marker Approaches?Digestive Diseases 2021; 39(3): 190 doi: 10.1159/000511641
5
Mariangela Manfredi, Lieve Van Hoovels, Maurizio Benucci, Riccardo De Luca, Carmela Coccia, Pamela Bernardini, Edda Russo, Amedeo Amedei, Serena Guiducci, Valentina Grossi, Xavier Bossuyt, Carlo Perricone, Maria Infantino. Circulating Calprotectin (cCLP) in autoimmune diseasesAutoimmunity Reviews 2023; 22(5): 103295 doi: 10.1016/j.autrev.2023.103295
6
Stanislaus Argeny, Anton Stift, Michael Bergmann, Martina Mittlböck, Svenja Maschke, Yushan Yang, Praminthra Chitsabesan, Stefan Riss. Prognostic value of preoperative neutrophil-to-lymphocyte ratio in Crohn’s diseaseWiener klinische Wochenschrift 2018; 130(11-12): 398 doi: 10.1007/s00508-018-1322-3
7
Effects of anti–TNF-alpha therapy on hemoglobin levels and anemia in patients with inflammatory bowel diseaseDigestive and Liver Disease 2020; 52(4): 400 doi: 10.1016/j.dld.2019.11.019
8
Gabriele Dragoni, Gert De Hertogh, Séverine Vermeire. The Role of Citrullination in Inflammatory Bowel Disease: A Neglected Player in Triggering Inflammation and Fibrosis?Inflammatory Bowel Diseases 2021; 27(1): 134 doi: 10.1093/ibd/izaa095
9
Maryam Salimi, Joseph Albert Karam, Matthew Willman, Jonathan Willman, Brandon Lucke-Wold, Shokoufeh Khanzadeh, Peyman Mirghaderi, Javad Parvizi. Neutrophil to Lymphocyte Ratio and Periprosthetic Joint Infection: A Systematic Review and Meta-AnalysisThe Journal of Arthroplasty 2024; 39(3): 831 doi: 10.1016/j.arth.2023.08.067
10
Y. González-Lama, J. Sanz, G. Bastida, J. Campos, R. Ferreiro, B. Joven, A. Gutiérrez, X. Juanola, B. Sicilia, R. Veroz, J.P. Gisbert, M. Chaparro, E. Domènech, M. Esteve, F. Gomollón. Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el tratamiento de pacientes con espondiloartritis asociada a enfermedad inflamatoria intestinalEnfermedad Inflamatoria Intestinal al Día 2017; 16(1): 1 doi: 10.1016/j.eii.2016.09.002
11
Rui Zhou, Ying Chang, Jing Liu, Min Chen, Hongling Wang, Meifang Huang, Shi Liu, Xiaobing Wang, Qiu Zhao. JNK Pathway-Associated Phosphatase/DUSP22 Suppresses CD4+ T-Cell Activation and Th1/Th17-Cell Differentiation and Negatively Correlates with Clinical Activity in Inflammatory Bowel DiseaseFrontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00781
12
Francisco Guilherme Cancela Penna, Rodrigo Macedo Rosa, Fernando H. Pereira, Pedro Ferrari Sales Cunha, Stella Cristina S. Sousa, Teresa Cristina A. Ferrari, Carlos Cara, Maria de Lourdes A. Ferrari. Combined evaluation of fecal calprotectin and C-reactive protein as a therapeutic target in the management of patients with Crohn's diseaseGastroenterología y Hepatología 2021; 44(2): 87 doi: 10.1016/j.gastrohep.2020.04.015
13
Djuna C de Jong, Mark Löwenberg, Ioannis Koumoutsos, Shuvra Ray, Joel Mawdsley, Simon Anderson, Jeremy D Sanderson, Krisztina Gecse, Cyriel Y Ponsioen, Geert R D’Haens, Peter M Irving, Mark A Samaan. Validation and Investigation of the Operating Characteristics of the Ulcerative Colitis Endoscopic Index of SeverityInflammatory Bowel Diseases 2019; 25(5): 937 doi: 10.1093/ibd/izy325
14
David T Rubin, Joana Torres, Iris Dotan, Lan Terry Xu, Irene Modesto, John C Woolcott, Sean Gardiner, Bruce E Sands. An Insight into Patients’ Perspectives of Ulcerative Colitis Flares via Analysis of Online Public Forum PostsInflammatory Bowel Diseases 2023;  doi: 10.1093/ibd/izad247
15
Marie Stute, Martin Kreysing, Markus Zorn, Patrick Michl, Annika Gauss. Serum Amyloid A as a Potential Biomarker in Inflammatory Bowel Diseases, Especially in Patients with Low C-Reactive ProteinInternational Journal of Molecular Sciences 2024; 25(2): 1177 doi: 10.3390/ijms25021177
16
Giovanni Grassi, Maria Elena Laino, Massimo Claudio Fantini, Giovanni Maria Argiolas, Maria Valeria Cherchi, Refky Nicola, Clara Gerosa, Giulia Cerrone, Lorenzo Mannelli, Antonella Balestrieri, Jasjit S. Suri, Alessandro Carriero, Luca Saba. Advanced imaging and Crohn’s disease: An overview of clinical application and the added value of artificial intelligenceEuropean Journal of Radiology 2022; 157: 110551 doi: 10.1016/j.ejrad.2022.110551
17
Bari Dane, Sean Duenas, Joseph Han, Thomas O'Donnell, Justin Ream, Shannon Chang, Alec Megibow. Crohn's Disease Activity Quantified by Iodine Density Obtained From Dual-Energy Computed Tomography EnterographyJournal of Computer Assisted Tomography 2020; 44(2): 242 doi: 10.1097/RCT.0000000000000986
18
Kimberly L. Klages, Kristoffer S. Berlin, Jessica L. Cook, Mary E. Keenan, Katherine Semenkovich, Gabrielle G. Banks, Tiffany M. Rybak, Rachel L. Ankney, Kristina M. Decker, John R. Whitworth, Mark R. Corkins. Examining Risk Factors of Health-Related Quality of Life Impairments Among Adolescents with Inflammatory Bowel DiseaseBehavioral Medicine 2021; 47(2): 140 doi: 10.1080/08964289.2019.1676193
19
Majken Lindholm, Antonio Di Sabatino, Tina Manon-Jensen, Giuseppe Mazza, Gunvor I. Madsen, Paolo Giuffrida, Massimo Pinzani, Aleksander Krag, Morten A. Karsdal, Jens Kjeldsen, Joachim H. Mortensen. A Serological Biomarker of Laminin Gamma 1 Chain Degradation Reflects Altered Basement Membrane Remodeling in Crohn’s Disease and DSS ColitisDigestive Diseases and Sciences 2022; 67(8): 3662 doi: 10.1007/s10620-021-07252-3
20
G. M. C. Adriaans, R. J. Almeida, D. Jonkers, T. van den Heuvel, A. G. L. Bodelier, M. J. Pierik. Analysis of biomarkers and composite scores in IBD patients using probabilistic fuzzy systems2022 IEEE International Conference on Fuzzy Systems (FUZZ-IEEE) 2022; : 1 doi: 10.1109/FUZZ-IEEE55066.2022.9882584
21
Jonathan Y. Xia, Chelsea Hepler, Peter Tran, Nathan J. Waldeck, Joseph Bass, Arthur Prindle. Engineered calprotectin-sensing probiotics for IBD surveillance in humansProceedings of the National Academy of Sciences 2023; 120(32) doi: 10.1073/pnas.2221121120
22
Cristina Carretero, Franck Carbonnel, Marc Ferrante, Torben Knudsen, Nancy Van Lent, Alan J. Lobo, Lucian Negreanu, Ana Vojvodic, Salvatore Oliva. Monitoring established Crohn’s disease with pan-intestinal video capsule endoscopy in Europe: clinician consultation using the nominal group techniqueCurrent Medical Research and Opinion 2021; 37(9): 1547 doi: 10.1080/03007995.2021.1940910
23
Olivier Benoit, Mathieu Faron, Nicolas Margot, Ben Creavin, Clotilde Debove, Emmanuel Tiret, Yann Parc, Jérémie H. Lefevre. C-Reactive Protein Values After Colorectal Resection: Can We Discharge a Patient With a C-Reactive Protein Value >100? A Retrospective Cohort StudyDiseases of the Colon & Rectum 2019; 62(1): 88 doi: 10.1097/DCR.0000000000001216
24
Samantha Conley, Sangchoon Jeon, Vanessa Lehner, Deborah D. Proctor, Nancy S. Redeker. Sleep Characteristics and Rest–Activity Rhythms Are Associated with Gastrointestinal Symptoms Among Adults with Inflammatory Bowel DiseaseDigestive Diseases and Sciences 2021; 66(1): 181 doi: 10.1007/s10620-020-06213-6
25
Francisco Guilherme Cancela Penna, Rodrigo Macedo Rosa, Fernando H. Pereira, Pedro Ferrari Sales Cunha, Stella Cristina S. Sousa, Teresa Cristina A. Ferrari, Carlos Cara, Maria de Lourdes A. Ferrari. Combined evaluation of fecal calprotectin and C-reactive protein as a therapeutic target in the management of patients with Crohn's diseaseGastroenterología y Hepatología (English Edition) 2021; 44(2): 87 doi: 10.1016/j.gastre.2020.04.010
26
Nghia H Nguyen, Dominic Picetti, Parambir S Dulai, Vipul Jairath, William J Sandborn, Lucila Ohno-Machado, Peter L Chen, Siddharth Singh. Machine Learning-based Prediction Models for Diagnosis and Prognosis in Inflammatory Bowel Diseases: A Systematic ReviewJournal of Crohn's and Colitis 2022; 16(3): 398 doi: 10.1093/ecco-jcc/jjab155
27
Lydia C. T. Buer, Bjørn A. Moum, Milada Cvancarova, David J. Warren, Nils Bolstad, Asle W. Medhus, Marte L. Høivik. Real world data on effectiveness, safety and therapeutic drug monitoring of vedolizumab in patients with inflammatory bowel disease. A single center cohortScandinavian Journal of Gastroenterology 2019; 54(1): 41 doi: 10.1080/00365521.2018.1548646
28
Sara Resende, Manuela F. Frasco, Paulo P. Freitas, M. Goreti F. Sales. Detection of serum calprotectin based on molecularly imprinted photonic hydrogels: A novel approach for IBD diagnosisBiosensors and Bioelectronics: X 2023; 13: 100313 doi: 10.1016/j.biosx.2023.100313
29
Mohamed Saleh Ismail, Diane E Peters, Steven P Rowe, Ali Salavati, Sowmya Sharma, Robert Anders, Martin Pomper, Barbara S Slusher, Florin M Selaru. PSMA-Targeted PET Radiotracer [18F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel DiseaseClinical and Experimental Gastroenterology 2023; : 237 doi: 10.2147/CEG.S404009
30
Terry Li, Benjamin Click, Salam Bachour, Michael Sachs, Edward L. Barnes, Benjamin L. Cohen, Susell Contreras, Jordan Axelrad. Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn’s DiseaseDigestive Diseases and Sciences 2023; 68(9): 3596 doi: 10.1007/s10620-023-08044-7
31
M. Pehrsson, M. S. Alexdóttir, M. A. Karsdal, P. Thakker, J.H. Mortensen. Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn’s diseaseExpert Review of Gastroenterology & Hepatology 2023; 17(6): 575 doi: 10.1080/17474124.2023.2212158
32
Liran Domachevsky, Haim Leibovitzh, Irit Avni-Biron, Lev Lichtenstein, Natalia Goldberg, Meital Nidam, David Groshar, Hanna Bernstine, Ofer Ben-Bassat. Correlation of 18F-FDG PET/MRE Metrics with Inflammatory Biomarkers in Patients with Crohn’s Disease: A Pilot StudyContrast Media & Molecular Imaging 2017; 2017: 1 doi: 10.1155/2017/7167292
33
Pasqua Letizia Pesole, Marina Liso, Rossella Donghia, Vito Guerra, Antonio Lippolis, Mauro Mastronardi, Palma Aurelia Iacovazzi. 90K/Mac-2 BP Is a New Predictive Biomarker of Response to Infliximab Therapy in IBD PatientsInternational Journal of Molecular Sciences 2023; 24(4): 3955 doi: 10.3390/ijms24043955
34
Changchang Ge, Yi Lu, Hong Shen, Lei Zhu. Monitoring of intestinal inflammation and prediction of recurrence in ulcerative colitisScandinavian Journal of Gastroenterology 2022; 57(5): 513 doi: 10.1080/00365521.2021.2022193
35
Isaiah P. Schuster, Leslie Klyachman, Ramona Rajapakse, Farah Monzur. Inflammatory Bowel DiseaseClinical Gastroenterology 2021; : 89 doi: 10.1007/978-3-030-81780-0_4
36
Kaushik Kondubhatla, Ayush Kaushal, Ali Daoud, Hassan Shabbir, Jihan A Mostafa. Pro-Atherogenic Inflammatory Mediators in Inflammatory Bowel Disease Patients Increase the Risk of Thrombosis, Coronary Artery Disease, and Myocardial Infarction: A Scientific DilemmaCureus 2020;  doi: 10.7759/cureus.10544
37
Stanley A. Cohen. Alas, Who and What Can We Trust? Patients, Parents, Surrogate Markers, or the Specific Carbohydrate DietJournal of Pediatric Gastroenterology and Nutrition 2017; 65(3): 266 doi: 10.1097/MPG.0000000000001665
38
Lorenzo Bertani, Gian Paolo Caviglia, Luca Antonioli, Rinaldo Pellicano, Sharmila Fagoonee, Marco Astegiano, Giorgio Maria Saracco, Elisabetta Bugianesi, Corrado Blandizzi, Francesco Costa, Davide Giuseppe Ribaldone. Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel DiseasesJournal of Clinical Medicine 2020; 9(5): 1323 doi: 10.3390/jcm9051323
39
Tadashi Ichimiya, Tomoe Kazama, Keisuke Ishigami, Yoshihiro Yokoyama, Yuki Hayashi, Satoshi Takahashi, Takao Itoi, Hiroshi Nakase, Emiko Mizoguchi. Application of plasma alternative to serum for measuring leucine-rich α2-glycoprotein as a biomarker of inflammatory bowel diseasePLOS ONE 2023; 18(6): e0286415 doi: 10.1371/journal.pone.0286415
40
Parul Tandon, Adam V. Weizman. Management of Inpatient Inflammatory Bowel Disease2022; : 91 doi: 10.1007/978-1-0716-1987-2_5
41
Soo-Kyung Park, Sang Hyun Park, Chang Soo Eun, Geom Seog Seo, Jong Pil Im, Tae Oh Kim, Dong-Il Park. Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized studyIntestinal Research 2019; 17(3): 349 doi: 10.5217/ir.2018.00064
42
Catherine Colman, Marlene Stone, Alain Bitton. Inflammatory Bowel Disease Nursing Manual2019; : 43 doi: 10.1007/978-3-319-75022-4_6
43
Francisco Guilherme Cancela e Penna, Rodrigo Macedo Rosa, Pedro Ferrari Sales da Cunha, Stella Cristina Silva de Souza, Maria de Lourdes de Abreu Ferrari. Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn’s diseaseBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-1183-x
44
Min Ju Kim, Mi-Rae Shin, Hak Joo Choi, Seong-Soo Roh. Study of the Effect and Underlying Mechanism of Enzyme-Treated Garlic Extract on a Lipopolysaccharide-Induced Acute Colitis ModelThe Journal of Internal Korean Medicine 2023; 44(6): 1243 doi: 10.22246/jikm.2023.44.6.1243
45
Adi Lahat, Ido Veisman. Capsule Endoscopy in Crohn’s Disease—From a Relative Contraindication to Habitual Monitoring ToolDiagnostics 2021; 11(10): 1737 doi: 10.3390/diagnostics11101737
46
Ziheng Peng, Duo Xu, Yong Li, Xiaowei Liu, Fujun Li, Yu Peng. A novel role of prognostic nutritional index in predicting the effectiveness of infliximab in Crohn's diseaseAnnals of Medicine 2023; 55(1) doi: 10.1080/07853890.2023.2236011
47
Ruoran Shi, Fazheng Yu, Xueyu Hu, Yan Liu, Yuanyuan Jin, Honglin Ren, Shiying Lu, Jian Guo, Jiang Chang, Yansong Li, Zengshan Liu, Xiaoxu Wang, Pan Hu. Protective Effect of Lactiplantibacillus plantarum subsp. plantarum SC-5 on Dextran Sulfate Sodium—Induced Colitis in MiceFoods 2023; 12(4): 897 doi: 10.3390/foods12040897
48
Matthew K. Doherty, Tao Ding, Charlie Koumpouras, Shannon E. Telesco, Calixte Monast, Anuk Das, Carrie Brodmerkel, Patrick D. Schloss, Claire M. Fraser. Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn’s Disease PatientsmBio 2018; 9(2) doi: 10.1128/mBio.02120-17
49
Jennifer C. Brazil, Charles A. Parkos. Finding the sweet spot: glycosylation mediated regulation of intestinal inflammationMucosal Immunology 2022; 15(2): 211 doi: 10.1038/s41385-021-00466-8
50
Yoshikazu Tsuzuki, Rie Shiomi, Hisashi Matsumoto, Kazuya Miyaguchi, Takeru Kusano, Hideki Ohgo, Hidetomo Nakamoto, Hiroyuki Imaeda. Combined effects of granulocyte and monocyte adsorption apheresis and corticosteroids on ulcerative colitisJournal of Clinical Biochemistry and Nutrition 2023; 72(1): 68 doi: 10.3164/jcbn.22-52
51
Yi-Hao Che, Zheng-Yong Yu, Fu-Neng Geng, Miao He, Zhi-Bin Yang, Yuan-Yuan Zheng, Cheng-Gui Zhang, Yu Zhao, Xiu-Mei Wu, Heng Liu. Effects of the Traditional Chinese Medicine Formula Ento-PB in Experimental Models of Ulcerative ColitisNatural Product Communications 2022; 17(3): 1934578X2210784 doi: 10.1177/1934578X221078453
52
Yahya Ozel, H. Kubra Elcioglu, Z. Ayca Cevikelli, Ilyas Kudas, Sarfraz Ahmad, Hafize Uzun, Cumhur Topal, Serife Aktas, Levent Kabasakal. Ischemic colitis of the colon in streptozotocin-induced diabetic ratsMolecular and Cellular Biochemistry 2018; 439(1-2): 87 doi: 10.1007/s11010-017-3138-2
53
Kamila Majidova, Julia Handfield, Kamran Kafi, Ryan D. Martin, Ryszard Kubinski. Role of Digital Health and Artificial Intelligence in Inflammatory Bowel Disease: A Scoping ReviewGenes 2021; 12(10): 1465 doi: 10.3390/genes12101465
54
Andres J Yarur, Michael V Chiorean, Julián Panés, Vipul Jairath, Jinkun Zhang, Christopher J Rabbat, William J Sandborn, Séverine Vermeire, Laurent Peyrin-Biroulet. Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS TrialJournal of Crohn's and Colitis 2024;  doi: 10.1093/ecco-jcc/jjae007
55
Glen Doherty, Konstantinos H Katsanos, Johan Burisch, Matthieu Allez, Konstantinos Papamichael, Andreas Stallmach, Ren Mao, Ingrid Prytz Berset, Javier P Gisbert, Shaji Sebastian, Jarosław Kierkuś, Loris Lopetuso, Edyta Szymanska, Edouard Louis. European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [‘Exit Strategies’] in Inflammatory Bowel DiseaseJournal of Crohn's and Colitis 2018; 12(1): 17 doi: 10.1093/ecco-jcc/jjx101
56
Claire Wang, Hannah M. Baer, Daniel R. Gaya, Robert J.B. Nibbs, Simon Milling. Can molecular stratification improve the treatment of inflammatory bowel disease?Pharmacological Research 2019; 148: 104442 doi: 10.1016/j.phrs.2019.104442
57
Wojciech Marlicz, Karolina Skonieczna-Żydecka, Konstantinos John Dabos, Igor Łoniewski, Anastasios Koulaouzidis. Emerging concepts in non-invasive monitoring of Crohn’s diseaseTherapeutic Advances in Gastroenterology 2018; 11: 175628481876907 doi: 10.1177/1756284818769076
58
Petra Weimers, Dorit Vedel Ankersen, Pia Munkholm. Biomarkers in Inflammatory Bowel Diseases2019; : 271 doi: 10.1007/978-3-030-11446-6_22
59
Vladislav Volarevic, Natasa Zdravkovic, Carl Randall Harrell, Nebojsa Arsenijevic, Crissy Fellabaum, Valentin Djonov, Miodrag L. Lukic, Bojana Simovic Markovic. Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative ColitisCells 2019; 8(7): 709 doi: 10.3390/cells8070709
60
Wu Yan, Wei Meihao, Song Zihan, Huang Lingjie, Chen Haotian, Cao Qian, Sun Lianli. Correlation Between Crohn's Disease Activity and Serum Selenium ConcentrationClinical Therapeutics 2022; 44(5): 736 doi: 10.1016/j.clinthera.2022.03.005
61
Yuzhan Jin, Mingtao Ma, Yuqing Yan, Yaoyi Guo, Yue Feng, Chen Chen, Yi Zhong, Kaizong Huang, Huaming Xia, Yan Libo, Yanna Si, Jianjun Zou. A convenient machine learning model to predict full stomach and evaluate the safety and comfort improvements of preoperative oral carbohydrate in patients undergoing elective painless gastrointestinal endoscopyAnnals of Medicine 2023; 55(2) doi: 10.1080/07853890.2023.2292778
62
Isabelle Noiseux, Sophie Veilleux, Alain Bitton, Rita Kohen, Luc Vachon, Brian White Guay, John D. Rioux. Inflammatory bowel disease patient perceptions of diagnostic and monitoring tests and proceduresBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0946-8
63
Alicja Derkacz, Paweł Olczyk, Agnieszka Jura-Półtorak, Krystyna Olczyk, Katarzyna Komosinska-Vassev. The Diagnostic Usefulness of Circulating Profile of Extracellular Matrix Components: Sulfated Glycosaminoglycans (sGAG), Hyaluronan (HA) and Extracellular Part of Syndecan-1 (sCD138) in Patients with Crohn’s Disease and Ulcerative ColitisJournal of Clinical Medicine 2021; 10(8): 1722 doi: 10.3390/jcm10081722
64
Thomas Dietze, Friedrich Anger, Daniel Bredenkötter, Christoph-Thomas Germer, Stefan Heinrich, Thea Höschel, Christoph Jänig, Maria Köhl, Uwe Krausbauer, Diana Sauer, Klaus Völker, Julia Wenzel, Jan Wittstamm. Notfälle in der Allgemein- und Viszeralchirurgie2019; : 383 doi: 10.1007/978-3-662-53557-8_28
65
Hiroshi Nakase, Motohiro Esaki, Fumihito Hirai, Taku Kobayashi, Katsuyoshi Matsuoka, Minoru Matsuura, Makoto Naganuma, Masayuki Saruta, Kiichiro Tsuchiya, Motoi Uchino, Kenji Watanabe, Tadakazu Hisamatsu, Akira Andoh, Shigeki Bamba, Motohiro Esaki, Mikihiro Fujiya, Kitaro Futami, Keisuke Hata, Fumihito Hirai, Sakiko Hiraoka, Tadakazu Hisamatsu, Ryota Hokari, Shunji Ishihara, Soichiro Ishihara, Michio Itabashi, Yoichi Kakuta, Jun Kato, Shingo Kato, Takehiko Katsurada, Kazuya Kitamura, Kiyonori Kobayashi, Taku Kobayashi, Kazutaka Koganei, Atsuo Maemoto, Toshiyuki Matsui, Takayuki Matsumoto, Katsuyoshi Matsuoka, Minoru Matsuura, Satoshi Motoya, Masakazu Nagahori, Makoto Naganuma, Yuji Naito, Shiro Nakamura, Hiroshi Nakase, Haruhiko Ogata, Kazuichi Okazaki, Hirotake Sakuraba, Masayuki Saruta, Shinichiro Shinzaki, Ken Sugimoto, Akira Sugita, Yasuo Suzuki, Kenichi Takahashi, Tomohisa Takagi, Kento Takenaka, Ken Takeuchi, Kiichiro Tsuchiya, Tomoyuki Tsujikawa, Motoi Uchino, Fumiaki Ueno, Kenji Watanabe, Mamoru Watanabe, Takayuki Yamamoto, Kaoru Yokoyama, Atsushi Yoshida, Naoki Yoshimura. Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021Journal of Gastroenterology 2023; 58(4): 313 doi: 10.1007/s00535-023-01958-z
66
Satoshi Motoya, Kenji Watanabe, Haruhiko Ogata, Takanori Kanai, Toshiyuki Matsui, Yasuo Suzuki, Mitsuhiro Shikamura, Kenkichi Sugiura, Kazunori Oda, Tetsuharu Hori, Takahiro Araki, Mamoru Watanabe, Toshifumi Hibi, John Green. Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled studyPLOS ONE 2019; 14(2): e0212989 doi: 10.1371/journal.pone.0212989
67
Meyya Bouazzi, Nina F. Bak, Jørgen Agnholt, Vibeke Wewer, Mikkel Malham, Mia Bendix, Jimmy K. Limdi. Paediatric Crohn’s Disease Patients Have Increased Inflammatory Markers Compared to Adult Patients prior to Biological TreatmentGastroHep 2022; 2022: 1 doi: 10.1155/2022/9550908
68
Fabien Beaufils, Emmanuel Mas, Marie Mittaine, Martin Addra, Michael Fayon, Laurence Delhaes, Haude Clouzeau, François Galode, Thierry Lamireau, Stéphanie Bui, Raphaël Enaud. Increased Fecal Calprotectin Is Associated with Worse Gastrointestinal Symptoms and Quality of Life Scores in Children with Cystic FibrosisJournal of Clinical Medicine 2020; 9(12): 4080 doi: 10.3390/jcm9124080
69
Enhui Ji, Tingting Wang, Jing Xu, Jianwei Fan, Yi Zhang, Yongxia Guan, Hongjun Yang, Junying Wei, Guimin Zhang, Luqi Huang. Systematic Investigation of the Efficacy of Sinitang Decoction Against Ulcerative ColitisFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01337
70
Aria Zand, Audrey Nguyen, Zack Stokes, Welmoed van Deen, Amy Lightner, Anya Platt, Rutger Jacobs, Sarah Reardon, Ellen Kane, Jonathan Sack, Daniel Hommes. Patient Experiences and Outcomes of a Telehealth Clinical Care Pathway for Postoperative Inflammatory Bowel Disease PatientsTelemedicine and e-Health 2020; 26(7): 889 doi: 10.1089/tmj.2019.0102
71
Eleni Orfanoudaki, Ioannis Drygiannakis, Eirini Theodoraki, Kalliopi Foteinogiannopoulou, Aikaterini Mantaka, Ioannis E. Koutroubakis. Real-life utility and diagnostic accuracy of a home-performed fecal calprotectin test to predict endoscopic activity in patients with inflammatory bowel disease under maintenance treatment with adalimumabEuropean Journal of Gastroenterology & Hepatology 2021; 33(1S): e777 doi: 10.1097/MEG.0000000000002248
72
Michael W. Winter, Joel V. Weinstock. The Autoimmune Diseases2020; : 871 doi: 10.1016/B978-0-12-812102-3.00046-4
73
Cristina Carretero, Alejandro Bojorquez, Rami Eliakim, Nikolaos Lazaridis. Updates in the diagnosis and management of small-bowel Crohn's diseaseBest Practice & Research Clinical Gastroenterology 2023; : 101855 doi: 10.1016/j.bpg.2023.101855
74
Michelle Stakenborg, Bram Verstockt, Elisa Meroni, Gera Goverse, Veronica De Simone, Sare Verstockt, Mario Di Matteo, Paulo Czarnewski, Eduardo J Villablanca, Marc Ferrante, Guy E Boeckxstaens, Massimiliano Mazzone, Séverine Vermeire, Gianluca Matteoli. Neutrophilic HGF-MET Signalling Exacerbates Intestinal InflammationJournal of Crohn's and Colitis 2020; 14(12): 1748 doi: 10.1093/ecco-jcc/jjaa121
75
Emma Buchan, Pola Goldberg Oppenheimer. Review–Vibrational spectroscopy‐aided diagnosis, prognosis and treatment of inflammatory bowel diseaseClinical and Translational Discovery 2023; 3(5) doi: 10.1002/ctd2.249
76
Imen Tanniche, Bahareh Behkam. Engineered live bacteria as disease detection and diagnosis toolsJournal of Biological Engineering 2023; 17(1) doi: 10.1186/s13036-023-00379-z
77
Ulf Helwig. Pflege bei chronisch-entzündlichen Darmerkrankungen2023; : 79 doi: 10.1007/978-3-662-64938-1_7
78
Melissa Furtado, Ryan J. Van Lieshout, Michael Van Ameringen, Sheryl M. Green, Benicio N. Frey. Biological and psychosocial predictors of anxiety worsening in the postpartum period: A longitudinal studyJournal of Affective Disorders 2019; 250: 218 doi: 10.1016/j.jad.2019.02.064
79
Majken Lindholm, Line E. Godskesen, Tina Manon-Jensen, Jens Kjeldsen, Aleksander Krag, Morten A. Karsdal, Joachim H. Mortensen. Endotrophin and C6Ma3, serological biomarkers of type VI collagen remodelling, reflect endoscopic and clinical disease activity in IBDScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-94321-2
80
Eleni Orfanoudaki, Maria Gazouli, Kalliopi Foteinogiannopoulou, Eirini Theodoraki, Evangelia Legaki, Ioannis Romanos, Ioannis Mouzas, Ioannis E. Koutroubakis. Infliximab trough levels are decreasing over time in patients with inflammatory bowel disease on maintenance treatment with infliximabEuropean Journal of Gastroenterology & Hepatology 2019; 31(2): 187 doi: 10.1097/MEG.0000000000001332
81
Marta Kramer Mikkelsen, Nana Aviaja Frederikke Lindblom, Anne Dyhl-Polk, Carsten Bogh Juhl, Julia Sidenius Johansen, Dorte Nielsen. Systematic review and meta-analysis of C-reactive protein as a biomarker in breast cancerCritical Reviews in Clinical Laboratory Sciences 2022; 59(7): 480 doi: 10.1080/10408363.2022.2050886
82
Shonit Nair Sharma, Yuhan Lee. Monitoring homeostasis with ultrasoundScience 2024; 383(6687): 1058 doi: 10.1126/science.ado2145
83
Jason Orlando Dimitri Musci, Jack Stephen Cornish, Jan Däbritz. Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseasesJournal of Gastroenterology 2016; 51(6): 531 doi: 10.1007/s00535-016-1191-3
84
Sebastian Fuchs, Nadia Sawas, Nicolas Staedler, David A. Schubert, Annalisa D'Andrea, Robert Zeiser, Luca Piali, Petr Hruz, Andreas P. Frei. High‐dimensional single‐cell proteomics analysis identifies immune checkpoint signatures and therapeutic targets in ulcerative colitisEuropean Journal of Immunology 2019; 49(3): 462 doi: 10.1002/eji.201847862
85
Vishal Sharma, Suhang Verma, Praveen Kumar-M, Harshal S. Mandavdhare, Harjeet Singh, Jimil Shah, Dimple Kalsi, Amitava Dutta, Shubhra Mishra, Kaushal K. Prasad, Arun K. Sharma, Usha Dutta. Serial measurements of faecal calprotectin may discriminate intestinal tuberculosis and Crohn’s disease in patients started on antitubercular therapyEuropean Journal of Gastroenterology & Hepatology 2021; 33(3): 334 doi: 10.1097/MEG.0000000000001879
86
Jie Chen, Xuejie Chen, Yuhao Sun, Ying Xie, Xiaoyan Wang, Ran Li, Therese Hesketh. The physiological and psychological effects of cognitive behavior therapy on patients with inflammatory bowel disease before COVID-19: a systematic reviewBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02003-0
87
Jun Pan, Jiao Li, Yuanjun Gao. The value of 7 peripheral blood serum ratios in diagnosis and prediction of disease activity of patients within inflammatory bowel disease individualsFrontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1122005
88
Piotr Eder, Kamila Stawczyk-Eder, Katarzyna Korybalska, Natasza Czepulis, Joanna Luczak, Liliana Lykowska-Szuber, Iwona Krela-Kazmierczak, Krzysztof Linke, Janusz Witowski. Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodiesWorld Journal of Gastroenterology 2017; 23(1): 135-140 doi: 10.3748/wjg.v23.i1.135
89
Riccardo Mager, Giulia Roda, Mohammad Khaled Shalaby, Stefania Vetrano. Fibrotic Strictures in Crohn’s Disease: Mechanisms and Predictive FactorsCurrent Drug Targets 2021; 22(2): 241 doi: 10.2174/1389450121666201020160803
90
Alessandro Vitello, Marcello Maida, Endrit Shahini, Fabio Salvatore Macaluso, Ambrogio Orlando, Mauro Grova, Daryl Ramai, Gaetano Serviddio, Antonio Facciorusso. Current Approaches for Monitoring of Patients with Inflammatory Bowel Diseases: A Narrative ReviewJournal of Clinical Medicine 2024; 13(4): 1008 doi: 10.3390/jcm13041008
91
Kourosh Masnadi Shirazi, Simin Sotoudeh, Arman Masnadi Shirazi, Seyyed-Yaghoub Moaddab, Zahra Nourpanah, Zeinab Nikniaz. Effect of N-acetylcysteine on remission maintenance in patients with ulcerative colitis: A randomized, double-blind controlled clinical trialClinics and Research in Hepatology and Gastroenterology 2021; 45(4): 101532 doi: 10.1016/j.clinre.2020.08.010
92
Yuko Okuyama, Yosuke Doi, Naoto Matsuyama, Michiyo Uchino, Takayuki Yamamoto. A novel sol particle immunoassay for fecal calprotectin in inflammatory bowel disease patientsClinica Chimica Acta 2016; 456: 1 doi: 10.1016/j.cca.2016.02.012
93
José Fernando Vera Chamorro, Claudia Sánchez Franco, Melquicedec Vargas Sandoval, Diana Victoria Mora Quintero, Juan Pablo Riveros López, Fernando Sarmiento Quintero, Catalina Ortiz-Piedrahita, Otto Gerardo Calderón-Guerrero, Hugo Laignelet, Claudia Liliana Losada Gómez, Diana Paola Sánchez, Rocío del Pilar López Panqueva, Wilmer Aponte Barrios, Gustavo Adolfo Triana Rodríguez, Adriana Osorno, Luis Miguel Becerra Granados, María Claudia Ortega López, Óscar Correa Jiménez, Silvia Juliana Maradei Anaya, Mary García Acero, Ana María Acevedo Forero, Adriana Prada, Luis Carlos Ramírez Urrego, Lina Karina Salcedo Castilla, Andrés Enríquez, María Alejandra Suárez Fuentes, Natalia González Leal, Stephania Peña Hernández, Lina Sotaquirá Guáqueta, Francisco Sosa, Fernando Fierro, Santiago Correa, Francisco Javier Martín de Carpi. Consenso colombiano de la enfermedad inflamatoria intestinal pediátricaRevista colombiana de Gastroenterología 2023; 38(Supl No. 1): 1 doi: 10.22516/25007440.943
94
Jimil Shah, Manik Lal Thakur, Usha Dutta. Mucosal healing in inflammatory bowel disease: Expanding horizonIndian Journal of Gastroenterology 2019; 38(2): 98 doi: 10.1007/s12664-019-00950-x
95
M. Nedim Ince, David E. Elliott. Effective Use of the Laboratory in the Management of Patients with Inflammatory Bowel DiseasesGastroenterology Clinics of North America 2019; 48(2): 237 doi: 10.1016/j.gtc.2019.02.006
96
Marcello Candelli, Laura Franza, Giulia Pignataro, Veronica Ojetti, Marcello Covino, Andrea Piccioni, Antonio Gasbarrini, Francesco Franceschi. Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel DiseasesInternational Journal of Molecular Sciences 2021; 22(12): 6242 doi: 10.3390/ijms22126242
97
Rebecca L. Smith, Kirstin M. Taylor, Antony B. Friedman, David J. Gibson, Danny Con, Peter R. Gibson. Early sonographic response to a new medical therapy is associated with future treatment response or failure in patients with inflammatory bowel diseaseEuropean Journal of Gastroenterology & Hepatology 2022; 34(6): 613 doi: 10.1097/MEG.0000000000002367
98
Carley Rusch, Matthew Beke, Lily Tucciarone, Katherine Dixon, Carmelo Nieves Jr., Volker Mai, Tamara Stiep, Tracy Tholanikunnel, Adolfo Ramirez-Zamora, Christopher W Hess, Bobbi Langkamp-Henken. Effect of a Mediterranean diet intervention on gastrointestinal function in Parkinson’s disease (the MEDI-PD study): study protocol for a randomised controlled trialBMJ Open 2021; 11(9): e053336 doi: 10.1136/bmjopen-2021-053336
99
Marijana Miler, Nora Nikolac Gabaj, Ivana Ćelap, Simeon Grazio, Vedran Tomašić, Alen Bišćanin, Joško Mitrović, Lovorka Đerek, Jadranka Morović-Vergles, Nada Vrkić, Mario Štefanović. Association of polymorphisms in promoter region of TNF-α -238 and -308 with clinical outcomes in patients with immune-mediated inflammatory diseases on anti-TNF therapyRheumatology International 2021; 41(12): 2195 doi: 10.1007/s00296-021-05016-w
100
Shubhra MISHRA, Sant RAM, Kaushal K PRASAD, Arun K SHARMA, Usha DUTTA, Vishal SHARMA. SERUM PROCALCITONIN AS A PROGNOSTIC MARKER IN ACUTE SEVERE ULCERATIVE COLITIS: A PROSPECTIVE STUDYArquivos de Gastroenterologia 2022; 59(1): 75 doi: 10.1590/s0004-2803.202200001-14
101
A. S. Strik, S. J. A. Bots, G. D’Haens, M. Löwenberg. Optimization of anti-TNF therapy in patients with Inflammatory Bowel DiseaseExpert Review of Clinical Pharmacology 2016; 9(3): 429 doi: 10.1586/17512433.2016.1133288
102
Oliver Grundmann. Gastrointestinal Inflammation and the Gut Microbiome: An Evolving Conceptual Framework with Implications for Diagnosis and Therapy in Inflammatory Bowel DisordersEMJ Microbiology & Infectious Diseases 2020; : 42 doi: 10.33590/emjmicrobiolinfectdis/20-00050
103
Ashish Dua, Vishal Sharma, Pankaj Gupta. Dual energy computed tomography in Crohn’s disease: a targeted reviewExpert Review of Gastroenterology & Hepatology 2022; 16(8): 699 doi: 10.1080/17474124.2022.2105203
104
Marie Vibeke Vestergaard, Kristine H. Allin, Gry J. Poulsen, James C. Lee, Tine Jess. Characterizing the pre-clinical phase of inflammatory bowel diseaseCell Reports Medicine 2023; 4(11): 101263 doi: 10.1016/j.xcrm.2023.101263
105
Ashley Vachon, Frank I. Scott. The treatment approach to inflammatory bowel disease in 2020Current Opinion in Gastroenterology 2020; 36(4): 247 doi: 10.1097/MOG.0000000000000653
106
Cristian Tefas, Radu Mărginean, Valentin Toma, Bobe Petrushev, Petra Fischer, Marcel Tanțău, Rareș Știufiuc. Surface-enhanced Raman scattering for the diagnosis of ulcerative colitis: will it change the rules of the game?Analytical and Bioanalytical Chemistry 2021; 413(3): 827 doi: 10.1007/s00216-020-03036-2
107
Cristiano Pagnini, Maria Benedetta Mariani, Vito Domenico Corleto, Gianfranco Delle Fave. Elevated C-Reactive Protein in Asymptomatic Crohnʼs Disease PatientsInflammatory Bowel Diseases 2017; 23(3): E13 doi: 10.1097/MIB.0000000000001030
108
Saemundur Jon Oddsson, Thrudur Gunnarsdottir, Lilja Gudrun Johannsdottir, Maria Lovisa Amundadottir, Arna Frimannsdottir, Pauliina Molander, Anna Karoliina Ylanne, Anna Sigridur Islind, Maria Oskarsdottir, Tryggvi Thorgeirsson. A New Digital Health Program for Patients With Inflammatory Bowel Disease: Preliminary Program EvaluationJMIR Formative Research 2023; 7: e39331 doi: 10.2196/39331
109
Lorenzo Bertani, Brigida Barberio, Marco Fornili, Luca Antonioli, Federico Zanzi, Cesare Casadei, Laura Benvenuti, Sonia Facchin, Vanessa D'Antongiovanni, Greta Lorenzon, Linda Ceccarelli, Laura Baglietto, Nicola de Bortoli, Massimo Bellini, Francesco Costa, Edoardo Vincenzo Savarino, Matteo Fornai. Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumabDigestive and Liver Disease 2022; 54(10): 1367 doi: 10.1016/j.dld.2022.03.008
110
Robert H. Mills, Yoshiki Vázquez-Baeza, Qiyun Zhu, Lingjing Jiang, James Gaffney, Greg Humphrey, Larry Smarr, Rob Knight, David J. Gonzalez, Marcus J. Claesson. Evaluating Metagenomic Prediction of the Metaproteome in a 4.5-Year Study of a Patient with Crohn's DiseasemSystems 2019; 4(1) doi: 10.1128/mSystems.00337-18
111
Rahul Kalla, Ray Boyapati, Simen Vatn, Gonzalo Hijos, Benjamin Crooks, Gregory Thomas Moore, Veronica Hall, George Lipscomb, Fernando Gomollón, Jørgen Jahnsen, Salil Singh. Patients’ perceptions of faecal calprotectin testing in inflammatory bowel disease: results from a prospective multicentre patient-based survey*Scandinavian Journal of Gastroenterology 2018; 53(12): 1437 doi: 10.1080/00365521.2018.1527394
112
Bhaskar Gurram, Ashish S. Patel. Recent advances in understanding and managing pediatric inflammatory bowel diseaseF1000Research 2019; 8: 2097 doi: 10.12688/f1000research.19609.1
113
Fang Liu, Seul A. Lee, Stephen M. Riordan, Li Zhang, Lixin Zhu. Global Studies of Using Fecal Biomarkers in Predicting Relapse in Inflammatory Bowel DiseaseFrontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.580803
114
Qiong Hu, Xing-zhou Tang, Fang Liu, De-wu Liu, Bo Cao. Vedolizumab subcutaneous formulation maintenance therapy for patients with IBD: a systematic review and meta-analysisTherapeutic Advances in Gastroenterology 2023; 16: 175628482311662 doi: 10.1177/17562848231166227
115
Marisa Iborra, Belén Beltrán, Pilar Nos. Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel DiseaseGastrointestinal Endoscopy Clinics of North America 2016; 26(4): 641 doi: 10.1016/j.giec.2016.06.005
116
Yael Ross, Stanley Ballou. Reliability of C-reactive protein as an inflammatory marker in patients with immune-mediated inflammatory diseases and liver dysfunctionRheumatology Advances in Practice 2023; 7(2) doi: 10.1093/rap/rkad045
117
Ting Zhang, Bota Cui, Pan Li, Zhi He, Chuyan Long, Lu Wei, Zhaoyuan Peng, Guozhong Ji, Faming Zhang, John Green. Short-Term Surveillance of Cytokines and C-Reactive Protein Cannot Predict Efficacy of Fecal Microbiota Transplantation for Ulcerative ColitisPLOS ONE 2016; 11(6): e0158227 doi: 10.1371/journal.pone.0158227
118
Olga Maria Nardone, Uday Nagesh Shivaji, Vittoria Ferruzza, Subrata Ghosh, Marietta Iacucci. Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive MonitoringInflammatory Bowel Diseases 2020; 26(6): 961 doi: 10.1093/ibd/izz226
119
Małgorzata Szczuko, Paulina Komisarska, Justyna Kikut, Arleta Drozd, Diana Sochaczewska. Calprotectin Is Associated with HETE and HODE Acids in Inflammatory Bowel DiseasesJournal of Clinical Medicine 2023; 12(24): 7584 doi: 10.3390/jcm12247584
120
Suja P. Davis, Linda P. Bolin, Patricia B. Crane, Holly Wei, Jamie Crandell. Non-pharmacological interventions to manage fatigue in adults with inflammatory bowel disease: A systematic review and meta-analysisComplementary Therapies in Clinical Practice 2020; 41: 101229 doi: 10.1016/j.ctcp.2020.101229
121
Jessica Gadsby, Karen Hall, Fathima Shah, Sanjeev Pattni, Sharon Gethins, Hussain Mulla. Infliximab: a single-centre, prospective, observational evaluation of TDM data in patients with IBDEuropean Journal of Hospital Pharmacy 2024; 31(1): 16 doi: 10.1136/ejhpharm-2021-003015
122
Gichang Kim, Mi Jang, Inguk Hwang, Jeongyong Cho, Saehun Kim. Radish sprout alleviates DSS-induced colitis via regulation of NF-kB signaling pathway and modifying gut microbiotaBiomedicine & Pharmacotherapy 2021; 144: 112365 doi: 10.1016/j.biopha.2021.112365
123
Way Seah Lee, Katsuhiro Arai, George Alex, Suporn Treepongkaruna, Kyung Mo Kim, Chee Liang Choong, Karen Calixto Mercado, Andy Darma, Anshu Srivastava, Marion M. Aw. Management and monitoring of pediatric inflammatory bowel disease in the Asia‐Pacific region: A position paper by the Asian Pan‐Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group: Surgical management, disease monitoring, and special considerationsJournal of Gastroenterology and Hepatology 2023; 38(4): 510 doi: 10.1111/jgh.16084
124
Alicja Derkacz, Pawel Olczyk, Katarzyna Komosinska-Vassev. Diagnostic Markers for Nonspecific Inflammatory Bowel DiseasesDisease Markers 2018; 2018: 1 doi: 10.1155/2018/7451946